Description
R30mg: Research Triple-Pathway Incretin Analog (GLP-1 / GIP / Glucagon) 1× GLP3-RTA (30mg)
Key Features
High-purity GLP3-RTA (≥99%) for precision metabolic research
Lyophilized powder for enhanced stability and accurate dosing
Analytical QC ensures batch consistency and purity
R30mg
GLP3-RTA (LY-3437943) – 30 MG
GLP3-RTA (LY-3437943) is a research-use-only peptide analog designed to interact with GLP-1, GIP, and glucagon receptor pathways. This compound is under investigation in metabolic research settings focused on obesity, type 2 diabetes, and related metabolic disorders.
Key Features:
Triple-pathway incretin research analog for advanced metabolic studies
Lyophilized for stability and dosing accuracy
QC verified for sequence fidelity and batch purity
Product Details:
Contents: 30 MG GLP3-RTA research peptide
Appearance: White to off-white lyophilized powder
Formula: C221H342N46O68
M.W.: ~4731.3 g/mol
CAS #: 2381089-83-2
Storage: Store at −20 °C; protect from moisture and light
Intended Use: For laboratory research use only
Note: Not for human or veterinary use. For in-vitro research only.





Reviews
There are no reviews yet.